Skip to main content
Top
Published in: Journal of Cancer Education 4/2020

01-08-2020 | Editorial

20 Years Later: Continued Relevance of Cancer, Culture, and Literacy in Cancer Education for Social Justice and Health Equity

Authors: Cathy D. Meade, Nathanael B. Stanley, Dinorah Martinez-Tyson, Clement K. Gwede

Published in: Journal of Cancer Education | Issue 4/2020

Login to get access

Excerpt

The persistence of health disparities is no longer a novel observation, but a well-documented reality whereby many populations have markedly unrelenting poorer levels of health. Inequities are influenced by complex historical and contemporary relationships between health and biology, and further affected by racism, discrimination, socioeconomic status, physical environment, literacy, and sexual orientation/gender identity to name a few [1, 2]. Recognition of such factors is essential for a norm of inclusion for achieving health equity [3]. As society globalizes through technological innovations and migration of populations, increasing prominence of cultural- and literacy-based research opportunities evolves in the field of cancer education. Crucially important is a need to assess, recognize, and address the effect of changing trends and recent events on cancer health disparities. In this editorial, we highlight the continued relevance of culture and health literacy in cancer education, and the promising opportunity that technology may play to advance health equity and social justice. …
Literature
5.
go back to reference Kagawa-Singer M, Dressler W, George SM, Elwood WN (2014) The cultural framework for health: an integrative approach for research and program design and evaluation. National Institutes of Health, Office of Behavioral and Social Sciences Research Kagawa-Singer M, Dressler W, George SM, Elwood WN (2014) The cultural framework for health: an integrative approach for research and program design and evaluation. National Institutes of Health, Office of Behavioral and Social Sciences Research
6.
go back to reference Institute of Medicine, Committee on Health Literacy. 2004. Culture and society. In Health literacy: a prescription to end confusion, eds. David A. Kindig, and Allison M. Panzer, and Lynn Nielsen-Bohlman. National Academies Press. Institute of Medicine, Committee on Health Literacy. 2004. Culture and society. In Health literacy: a prescription to end confusion, eds. David A. Kindig, and Allison M. Panzer, and Lynn Nielsen-Bohlman. National Academies Press.
8.
go back to reference Ratzan, S.C., .LO. Gostin, N. Meshkati, K. Rabin, and R.M. Parker. 2020. COVID-19: an urgent call for coordinated, trusted sources to tell everyone what they need to know and do. NAM Perspectives. Ratzan, S.C., .LO. Gostin, N. Meshkati, K. Rabin, and R.M. Parker. 2020. COVID-19: an urgent call for coordinated, trusted sources to tell everyone what they need to know and do. NAM Perspectives.
9.
go back to reference Freeman HP (2004) Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin 54(2):72–77CrossRef Freeman HP (2004) Poverty, culture, and social injustice: determinants of cancer disparities. CA Cancer J Clin 54(2):72–77CrossRef
10.
go back to reference Regnante JM, Richie NA, Fashoyin-Aje L, Vichnin M, Ford M, Roy UB, Turner K, Hall LL, Gonzalez E, Esnaola N, Clark LT, Adams HC III, Alese OB, Gogineni K, McNeill L, Petereit D, Sargeant I, Dang J, Obasaju C, Highsmith Q, Lee SC, Hoover SC, Williams EL, Chen MS Jr (2019) US cancer centers of excellence strategies for increased inclusion of racial and ethnic minorities in clinical trials. J Oncol Pract 15(4):e289–e299. https://doi.org/10.1200/JOP.18.00638 CrossRefPubMed Regnante JM, Richie NA, Fashoyin-Aje L, Vichnin M, Ford M, Roy UB, Turner K, Hall LL, Gonzalez E, Esnaola N, Clark LT, Adams HC III, Alese OB, Gogineni K, McNeill L, Petereit D, Sargeant I, Dang J, Obasaju C, Highsmith Q, Lee SC, Hoover SC, Williams EL, Chen MS Jr (2019) US cancer centers of excellence strategies for increased inclusion of racial and ethnic minorities in clinical trials. J Oncol Pract 15(4):e289–e299. https://​doi.​org/​10.​1200/​JOP.​18.​00638 CrossRefPubMed
11.
go back to reference Niranjan SJ, Durant RW, Wenzel JA, Cook ED, Fouad MN, Vickers SM, Konety BR, Rutland SB, Simoni ZR, Martin MY (2019) Training needs of clinical and research professionals to optimize minority recruitment and retention in cancer clinical trials. J Cancer Educ 34(1):26–34CrossRef Niranjan SJ, Durant RW, Wenzel JA, Cook ED, Fouad MN, Vickers SM, Konety BR, Rutland SB, Simoni ZR, Martin MY (2019) Training needs of clinical and research professionals to optimize minority recruitment and retention in cancer clinical trials. J Cancer Educ 34(1):26–34CrossRef
12.
go back to reference Lippman SM, Abate-Shen C, Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR (2018) AACR White Paper: shaping the future of cancer prevention–a roadmap for advancing science and public health. Cancer Prev Res 11(12):735–778CrossRef Lippman SM, Abate-Shen C, Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR (2018) AACR White Paper: shaping the future of cancer prevention–a roadmap for advancing science and public health. Cancer Prev Res 11(12):735–778CrossRef
14.
go back to reference U.S. Department of Health and Human Services. 2011. HHS action plan to reduce racial and ethnic disparities: a nation free of disparities in health and health care: U.S. Department of Health and Human Services. U.S. Department of Health and Human Services. 2011. HHS action plan to reduce racial and ethnic disparities: a nation free of disparities in health and health care: U.S. Department of Health and Human Services.
Metadata
Title
20 Years Later: Continued Relevance of Cancer, Culture, and Literacy in Cancer Education for Social Justice and Health Equity
Authors
Cathy D. Meade
Nathanael B. Stanley
Dinorah Martinez-Tyson
Clement K. Gwede
Publication date
01-08-2020
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 4/2020
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-020-01817-y

Other articles of this Issue 4/2020

Journal of Cancer Education 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine